PACIRA PHARMACEUTICALS INC - NOTE 3.250% 2/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2019

Type / Class
Debt / NOTE 3.250% 2/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of PACIRA PHARMACEUTICALS INC - NOTE 3.250% 2/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2019 Q1 $0 $0 -$55,000 0
2018 Q4 $104,502 $3,260,000 2242.62% 2
2018 Q3 $30,000 $61,000 203.33% 1
2018 Q2 $30,000 $43,000 143.33% 1
2018 Q1 $30,000 $42,000 140.0% 1
2017 Q4 $30,000 $57,000 190.0% 1
2017 Q3 $30,000 $49,000 163.33% 1
2017 Q2 $30,000 $60,000 -$908,000 200.0% 1
2017 Q1 $509,000 $965,000 -$160,093,808 189.78% 2
2016 Q4 $114,070,000 $160,570,000 +$6,578,232 140.88% 16
2016 Q3 $103,192,000 $155,520,000 +$2,238,196 150.81% 13
2016 Q2 $101,799,000 $152,010,000 -$10,260,761 148.69% 13
2016 Q1 $105,112,000 $232,506,000 -$9,008,968 221.27% 15
2015 Q4 $109,121,000 $340,385,000 +$33,378,143 311.96% 16
2015 Q3 $99,805,000 $174,021,000 -$2,270,670 173.91% 15
2015 Q2 $97,739,000 $278,276,000 +$12,340,292 284.97% 12
2015 Q1 $91,714,000 $328,221,000 +$6,635,377 357.6% 16
2014 Q4 $89,871,000 $322,121,000 -$7,301,995 357.94% 16
2014 Q3 $91,590,000 $358,274,000 -$15,776,453 390.98% 12
2014 Q2 $95,792,000 $357,588,000 +$266,058,000 373.12% 14
2014 Q1 $3,152,000 $8,969,000 +$1,665,000 284.55% 2